Cargando…

Clinical outcomes of low-dose leflunomide for rheumatoid arthritis complicated with Hepatitis B virus carriage and safety observation

OBJECTIVE: To study the clinical outcomes of low-dose leflunomide for rheumatoid arthritis (RA) complicated with hepatitis B virus (HBV) carriage and to observe the safety. METHODS: A total of 115 RA patients were divided into three groups according to the state of HBV. They were all given leflunomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ming-Xu, Hua, Chen, Meng, Cai, Yun, Yan-Jia, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476334/ https://www.ncbi.nlm.nih.gov/pubmed/26101483 http://dx.doi.org/10.12669/pjms.312.6673

Ejemplares similares

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Jones, Peter BB, et al.
Publicado: (2010)

The Effect of Leflunomide on Cold and Vibratory Sensation in Patients with Rheumatoid Arthritis
por: Kim, Hyung Kuk, et al.
Publicado: (2012)

Leflunomide-induced and paraneoplastic ulcers in a rheumatoid arthritis patient
por: Vittori, Michael R., et al.
Publicado: (2022)

Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
por: Shashikumar, N.S., et al.
Publicado: (2010)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
por: Gualberto Cardoso, Pablo Ramon, et al.
Publicado: (2021)

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis
por: Chen, Fang, et al.
Publicado: (2022)

Tripterygium Glycosides Combined with Leflunomide for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Yang, Yi-Jing, et al.
Publicado: (2020)

The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis
por: Chen, Yulan, et al.
Publicado: (2023)

Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology
por: Carubbi, Francesco, et al.
Publicado: (2019)

Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis
por: Huang, Yao, et al.
Publicado: (2019)

Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Zhang, Xiaogang, et al.
Publicado: (2022)

Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
por: Lee, Sang-Won, et al.
Publicado: (2012)

The Efficacy and Safety of the Combination of Total Glucosides of Peony and Leflunomide for the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis
por: Feng, Zhitao, et al.
Publicado: (2016)

Clinical efficacy and safety of methotrexate compared with leflunomide in the treatment of rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Qi, Weiyu, et al.
Publicado: (2021)

Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study
por: Kellner, Herbert, et al.
Publicado: (2010)

Brain abscess in a rheumatoid arthritis patient treated with leflunomide – A case presentation and review
por: Samara, Efthymia, et al.
Publicado: (2021)

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
por: Wiese, Michael D, et al.
Publicado: (2012)

Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis
por: Krishnan, Yadhu, et al.
Publicado: (2018)

Non-healing tongue ulcer in a rheumatoid arthritis patient medicated with leflunomide. An adverse drug event?
por: Kalogirou, Eleni-Marina, et al.
Publicado: (2017)

Leflunomide-Induced Immune-Mediated Necrotizing Myopathy in a Patient With Rheumatoid Arthritis: A Case Report
por: Salazar, Dylan Matthew, et al.
Publicado: (2023)

Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis
por: Liu, Ying, et al.
Publicado: (2022)

Traditional Chinese medicine Biqi capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trial
por: Wang, Zhang, et al.
Publicado: (2020)

Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide
por: Dziedziejko, Violetta, et al.
Publicado: (2011)

IL-22-producing CD4+T cells in the treatment response of rheumatoid arthritis to combination therapy with methotrexate and leflunomide
por: Zhong, Wei, et al.
Publicado: (2017)

Dystrophic calcinosis in a patient with overlap syndrome (scleroderma and rheumatoid arthritis) treated by leflunomide: A case report
por: Lee, Sang Yeob, et al.
Publicado: (2018)

Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial
por: Zhang, Chi, et al.
Publicado: (2019)

Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study
por: Dubey, Lily, et al.
Publicado: (2016)

Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial
por: Wijesinghe, Harindu, et al.
Publicado: (2017)

Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study
por: Dai, Xiaomin, et al.
Publicado: (2020)

Monitoring of Peripheral Blood Leukocytes and Plasma Samples: A Pilot Study to Examine Treatment Response to Leflunomide in Rheumatoid Arthritis
por: Rodrigues, João F. S., et al.
Publicado: (2021)

Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
por: Behrens, Frank, et al.
Publicado: (2021)

Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis
por: Łączna, Małgorzata, et al.
Publicado: (2021)

Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
por: Li, Yebei, et al.
Publicado: (2021)

A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs
por: Sato, M., et al.
Publicado: (2017)

Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)
por: Koehm, Michaela, et al.
Publicado: (2022)

Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review
por: Keng, Li-Ta, et al.
Publicado: (2016)

Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study
por: Deng, Daihua, et al.
Publicado: (2020)

HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
por: Liang, Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1jp8fed1j3pl8barh77t1mn27k